StockData
Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc. (PYXS) stock

PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.41−0.03 (-2.08%)

Close on Nov 18, 2026Market cap $117.61MP/E –Yield –

Pyxis Oncology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Pyxis Oncology's market cap was $104.03M on Nov 11, 2026, against $322.56M a year earlier. Over the last 5 years it ranged from $15.64M to $322.56M, with a median of $93.34M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$104.03M+45.6%
2025Dec 31, 2025$71.47M-22.9%
2024Dec 31, 2024$92.74M+16.3%
2023Dec 29, 2023$79.73M+82.6%
2022Dec 30, 2022$43.67M+142.8%
2021Dec 31, 2021$17.99M–

More Pyxis Oncology figures

See a number that looks wrong?